Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


WEST PHARM SVC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2018201720162015201420132012201120102009
Period End Date12/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/201212/31/201112/31/201012/31/2009
Sales1,717.401,599.101,509.101,399.801,421.401,368.401,266.401,192.301,104.701,055.70
Total Revenue1,717.401,599.101,509.101,399.801,421.401,368.401,266.401,192.301,104.701,055.70
Cost of goods and services sold1,172.001,086.201,007.70944.00973.60933.70878.70853.00786.60752.10
Gross Profit545.40512.90501.40455.80447.80434.70387.70339.30318.10303.60
Research and development40.3039.1036.8034.1037.3037.9033.2029.1023.9019.90
Selling, general and administrative expenses262.90246.00239.60233.00228.70234.90218.10191.10187.70177.70
Restructuring charge (benefit)--------------9.5015.808.50
Other expense (income), net(1.90)(2.00)(29.80)(60.10)0.200.50(1.30)------
Insurance settlement--------------------
Operating Income (Loss)240.30225.80195.20128.60182.00162.40135.10109.6090.7097.50
Interest expense8.407.808.1014.1016.5017.0016.7018.2016.8015.20
Interest income2.101.301.101.603.501.901.801.300.600.80
Other nonoperating income6.703.101.60--------------
Gain (Loss) on debt extinguishment----------(0.20)(11.60)0.000.00--
Income (loss) before income taxes240.70222.40189.80116.10169.00147.10108.6092.7074.5083.10
Provision for income taxes41.4080.9054.4026.3047.2040.2032.7023.5013.6013.50
Current provision:Federal2.102.102.501.005.200.000.00--0.600.30
Current provision-State3.300.101.000.900.501.700.20--0.200.10
Deferred provision:Federal1.4041.8021.80(13.20)7.709.203.302.70(0.50)(5.10)
Current provision:International35.1037.0029.4033.3034.5038.2027.2020.6014.6017.90
Deferred provision:International(0.50)(0.10)(0.30)4.30(0.70)(7.50)2.000.20(1.30)0.30
Minority interests--------------------
Equity in Net Income of Affiliated Companies7.609.208.205.805.305.404.806.304.403.00
Income from Continuing Operations--------------------
Discontinued operations, net of tax--------------------
Earnings (loss) from discontinued operations, net of tax--------------------
Income tax benefit from discontinued operations--------------------
Pretax income (loss) from discontinued operations--------------------
Pretax gain (loss) on disposal of business segment--------------------
Income (Loss) on disposal of discontinued operations, net of tax--------------------
Net Income (loss)--------------------
Less: Net income attributable to noncontrolling interests--------------------
Net income (loss) attributable to common shareholders206.90150.70143.6095.60127.10112.3080.7075.5065.3072.60
Net income (loss) for diluted net income per share----------------69.6076.90
Basic:Continuing operations--------------------
Basic:Discontinued operations--------------------
Net income per share- Basic2.802.041.961.331.791.611.191.120.981.11
Dilution:Continuing operations--------------------
Dilution:Discontinued operations--------------------
Net income per share- Diluted2.741.991.911.301.751.571.151.080.951.06
Weighted Average Shares Outstanding (Basic)73.9073.9073.3072.0070.9069.6068.1067.3066.6065.60
Weighted Average Shares Outstanding (Diluted)75.4075.8075.0073.8072.8071.4071.8074.0073.4072.60